Home merck
 

Keywords :   


Tag: merck

Sanofi Pasteur and Merck (Known as MSD Outside the United States and Canada) Announce Intent to End Joint Vaccines Operations in Europe, Sanofi Pasteur MSD, to Pursue Their Own Distinct Growth Strategies

2016-03-08 14:00:00| Merck.com - Corporate News

Dateline City: KENILWORTH, N.J. & LYON, France KENILWORTH, N.J. & LYON, France--(BUSINESS WIRE)--Sanofi Pasteur and Merck, known as MSD outside the United States and Canada, today announced their intent to end their joint vaccines operations in Europe. Upon concluding their joint venture, both companies plan to integrate their respective European vaccine businesses into their operations, independently manage their product portfolios and pursue their own distinct growth strategies in Europe. Language: English Contact: MerckMedia:Lainie Keller, 908-236-5036orInvestor:Justin Holko, 908-740-1879orSanofi PasteurMedia:Alain Bernal, +33 4 37 37 50 38orInvestor:Sébastien Martel, +33 1 53 77 45 45 Ticker Slug: Ticker: MRK Exchange: NYSE Ticker: SAN Exchange: BOURSE Ticker: SNY Exchange: NYSE read more

Tags: to their end own

 

Kanaly Trust Co. Has $2,067,000 Stake in Merck & Co., Inc.

2016-03-08 06:20:25| Biotech - Topix.net

Kanaly Trust Co. cut its position in shares of Merck & Co., Inc. by 2.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission .

Tags: co inc trust stake

 
 

Merck Names Sanat Chattopadhyay President of Merck Manufacturing Division; Will Succeed Willie A. Deese Who Will Retire

2016-03-07 22:30:00| Merck.com - Corporate News

Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the appointment of Sanat Chattopadhyay as executive vice president and president, Merck Manufacturing Division (MMD), effective April 1, 2016. Chattopadhyay will succeed Willie A. Deese who will retire on June 1, 2016 after 12 years with the company. Language: English Contact: MerckMedia:Lainie Keller, 908-236-5036orClaire Gillespie, 267-305-0932orInvestor:Teri Loxam, 908-740-1986orJustin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: will names president division

 

Security National Trust Co. Increases Position in Merck & Co., Inc.

2016-03-05 12:52:09| Biotech - Topix.net

Security National Trust Co. boosted its position in shares of Merck & Co., Inc. by 0.6% during the fourth quarter, according to its most recent filing with the SEC.

Tags: co inc national security

 

Merck and the Mectizan Donation Program Donate $1 Million to the END Fund for Efforts to Help Eliminate River Blindness in Africa

2016-03-04 16:00:00| Merck.com - Corporate News

Dateline City: KENILWORTH, N.J. Since 1987 Merck Has Donated More than Two Billion Treatments of Mectizan to Help Eliminate River Blindness and Lymphatic Filariasis KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the company, together with the Mectizan Donation Program, is donating $1 million to the END Fund in support of efforts in Africa to eliminate river blindness, which is also known as onchocerciasis. Language: English Contact: For Media:Jennifer Allen Woodruff, 267-305-3550orLainie Keller, 908-236-5036orFor Investors:Teri Loxam, 908-740-1986orJustin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: in to end program

 

Sites : [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] next »